Schroders to rename Medical Discovery fund

Schroders is to change the name of its £74m Medical Discovery fund as it brings the fund in line with competitors.

The fund, which is top decile in the UK Investment Management Association (IMA) Global sector over one, three and five years, will be renamed Schroder Global Healthcare on 7 December.

John Bowler will continue to manage the vehicle, which will see no change to its investment objective.

“The new name will help to increase the fund’s appeal and bring it in line with a number of similar competitor funds,” said Robin Stoakley, managing director of Schroders UK intermediary.

The fund has returned 39.7% over the three years to 2 November, according to Morningstar, compared with an IMA Global sector average of 22.1%. Over five years it has returned 56% compared with a sector average of 8.4%.


This article was first published on Investment Week

Close Window
View the Magazine

I also agree to receive editorial emails from InvestmentEurope
I also agree to receive event communications for InvestmentEurope
I also agree to receive other communications emails from InvestmentEurope
I agree to the terms of service *

You need to fill all required fields!